1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world. Symptomatic relief during the inflammation provides relief to the patients suffering from inflammatory autoimmune diseases. Although there are multiple anti-inflammatory drugs approved in the market, there is an indispensable need for better and novel anti-inflammatory therapeutics with lesser side effects and better efficacy.The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% over the forecast period, owing to the emergence of anti-inflammatory biologics that are more targeted, effective and with lesser side effects as compared to conventional drugs. In addition, they are also difficult to imitate due to their complex molecular structure and origin. The global anti-inflammatory market has been driven by factors such as increasing autoimmune and respiratory conditions, new drugs in pipeline and increasing adoption of anti-inflammatory drugs. Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives in the Asia-Pacific and LAMEA region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade), are known to impede the market growth.The global anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and geography. The indications considered in this report include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease and other inflammatory diseases. Among indications, arthritis holds tremendous potential for growth accounting for 38.2% of the global anti-inflammatory therapeutics market. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis. On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for 54.8% share of the global anti-inflammatory therapeutics market, and is expected grow rapidly during the forecast period.Geographically, the market is segmented into four regions namely North America, Europe, Asia-Pacific and LAMEA. Among regions, North America holds the largest share accounting for 45.7% share of the global anti-inflammatory therapeutics market; however, the Asia-Pacific region is expected to exhibit the fastest growth during the forecast period. Major market players have adopted innovative strategies such novel drug development and product launch (novel and indication expansion) to increase their market presence. In 2014, AstraZeneca had five anti-inflammatory drugs in the final stages of drug development. These drugs are lesinurad, sifalimumab, anifrolumab, mavrilimumab and brodalumab. The companies have filed new patents to overcome the issues of patent expiries of their existing drugs, and to gain a prominent market share. The key companies profiled in this report include Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline, Merck & CO., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, and Amgen.KEY MARKET BENEFITS:The report provides a quantitative analysis of the current market and estimations during 2014 - 2020 that assist in identifying the prevailing market opportunities to capitalize.Exhaustive analysis of the global anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics that are currently being used along with the categories that would gain prominence in the future.Competitive intelligence (of leading manufacturers and distributors of anti-inflammatory therapeutics) helps in understanding the competitive scenario across the geographies.Comprehensive analysis of factors that drive and restrict the growth of the global anti-inflammatory therapeutics market is provided.SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.The Country level analysis of anti-inflammatory therapeutics market conditions has been provided in this report.

KEY MARKET SEGMENTS
:The Global Anti-inflammatory Therapeutics Market is segmented below:Global Anti-inflammatory Therapeutics Market By IndicationArthritisRespiratory diseasesMultiple sclerosisPsoriasisInflammatory bowel diseaseOther inflammatory diseasesGlobal Anti-inflammatory Therapeutics Market Drug ClassAnti-inflammatory BiologicsNon-Steroidal Anti-inflammatory drugs (NSAIDs)CorticosteroidsGlobal Anti-inflammatory Therapeutics Market By GeographyNorth AmericaU.S.CanadaMexicoEuropeU.K.GermanyFranceOthersAsia-PacificChinaJapanIndiaOthersLAMEALatina AmericaMiddle East and Africa

Table Of Contents

World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020
Chapter: 1 INTRODUCTION1.1 Report Description1.2 Key Market Benefits1.3 Key Market Segments1.4 Research Methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsChapter: 2 EXECUTIVE SUMMARY2.1 CXO Perspective2.2 Market Beyond What to Expect by 2025 ($million)2.2.1 Moderate growth scenario2.2.2 Rapid growth scenario2.2.3 Diminishing growth scenarioChapter: 3 MARKET OVERVIEW3.1 Market Definition and Scope3.2 Key Findings3.2.1 Top impacting factors3.2.2 Top investment pockets3.2.3 Top winning strategies3.3 Government Regulation3.4 Reimbursement Scenario3.5 Porterand#39;s Five Force Analysis3.5.1 Complex and highly differentiated nature of raw materials increases bargaining power of suppliers3.5.2 Fewer manufacturers of anti-inflammatory drugs limits the bargaining power of buyers3.5.3 High capital investment and patent provision lowers the threats from new entrants3.5.4 Difficulty to imitate the original biologics lowers the threat of substitutes3.5.5 Industry rivalry is low to moderate due to presence of few competitors3.6 Value Chain Analysis3.7 Market Share Analysis, 20143.8 Market Dynamics3.8.1 Drivers3.8.1.1 Rising incidences of autoimmnue and respiratory conditions:3.8.1.2 New Drugs in Pipeline3.8.1.3 Increasing adoption rate of anti-inflammatory drugs3.8.2 Restraints3.8.2.1 Side effects of anti-inflammtory drugs3.8.2.2 Patenet expiries3.8.3 Opportunities3.8.3.1 Developing biosimilars for the existing drugs3.8.3.2 Tapping the emerging markets in developing regionsChapter: 4 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY INDICATION4.1 Market size and forecast by Indication4.2.1 Market size and forecast by region4.2.2 Rheumatoid Arthritis4.2.3 Osteoarthritis4.2.4 Ankylosing Spondylitis4.2.5 Psoriatic Arthritis4.2.6 Gout4.3 Respiratory Diseases4.3.1 Market size and forecast by region4.3.2 Asthma4.3.3 Chronic obstructive pulmonary disease (COPD)4.4 Multiple Sclerosis4.4.1 Market size and forecast by region4.5 Psoriasis4.5.1 Market size and forecast by region4.6 Inflammatory Bowel Disease (IBD)4.6.1 Market size and forecast by region4.6.2 Crohnand#39;s Disease4.6.3 Ulcerative Colitis4.7 Other Inflammatory Diseases4.7.1 Market size and forecast by regionChapter: 5 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS5.1 Anti-inflammatory Biologics5.1.1 Key market trend5.1.2 Market growth factors and opportunities5.1.3 Market size and forecast by region5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)5.2.1 Key market trend5.2.2 Market growth factors and opportunities5.2.3 Market size and forecast by region5.3 Corticosteroids5.3.1 Key market trends5.3.2 Market growth factors and opportunities5.3.3 Market size and forecast by region5.4 Other Anti-Inflammatory DrugsChapter: 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY6.1 North America6.1.1 Key market trends6.1.2 Key growth factors and opportunities6.1.3 Market size and forecast6.1.4 United States6.1.5 Canada6.1.6 Mexico6.2 Europe6.2.1 Key market trends6.2.2 Key growth factors and opportunities6.2.3 Market size and forecast6.2.4 United Kingdom6.2.5 Germany6.2.6 France6.2.7 Rest of Europe6.3 Asia Pacific6.3.1 Key growth factors and opportunities6.3.2 Market size and forecast6.3.3 Japan6.3.4 China6.3.5 India6.3.6 Rest of Asia Pacific6.4 LAMEA6.4.1 Key market trends6.4.2 Key growth factors and opportunities6.4.3 Market size and forecast6.4.4 Latin America6.4.5 Middle East and AfricaChapter: 7 COMPANY PROFILES7.1 Pfizer Inc.7.1.1 Company overview7.1.2 Company snapshot7.1.3 Business performance7.1.4 Strategic moves and developments7.1.5 SWOT analysis of Pfizer, Inc.7.2 AbbVie Inc.7.2.1 Company overview7.2.2 Company snapshot7.2.3 Business performance7.2.4 Strategic Moves and Developments7.2.5 SWOT analysis of AbbVie Inc.7.3 Johnson andamp; Johnson7.3.1 Company overview7.3.2 Company snapshot7.3.3 Business performance7.3.4 Strategic moves and developments7.3.5 SWOT analysis andamp; strategic conclusions7.4 GlaxoSmithKline plc7.4.1 Company overview7.4.2 Company snapshot7.4.3 Business performance7.4.4 Strategic moves and developments7.4.5 SWOT analysis andamp; strategic conclusions7.5 Merck andamp; Co., Inc.7.5.1 Company overview7.5.2 Company snapshot7.5.3 Business performance7.5.4 Strategic moves and developments7.5.5 SWOT analysis and strategic conclusions7.6 Novartis AG7.6.1 Company overview7.6.2 Company snapshot7.6.3 Business Performance7.6.4 Strategic moves and developments7.6.5 SWOT analysis and strategic conclusions7.7 F. Hoffmann-La Roche AG7.7.1 Company overview7.7.2 Company snapshot7.7.3 Business performance7.7.4 Strategic moves and developments7.7.5 SWOT analysis and strategic conclusions7.8 Eli Lily and Company7.8.1 Company overview7.8.2 Company snapshot7.8.3 Business performance7.8.4 Strategic moves and developments7.8.5 SWOT analysis and strategic conclusions7.9 AstraZeneca PLC.7.9.1 Company overview7.9.2 Company snapshot7.9.3 Business performance7.9.4 Strategic moves and developments7.9.5 SWOT analysis and strategic conclusions7.10 Amgen Inc.7.10.1 Company overview7.10.2 Company snapshot7.10.3 Business performance7.10.4 Strategic moves and developments7.10.5 SWOT analysis and strategic conclusionsLIST OF FIGURESFIG. 1 TOP IMPACTING FACTORS, MODERATE GROWTH SCENARIO (2020-2025)FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)FIG. 4 TYPES OF ANTI-INFALMMATORY THERAPEUTICS:FIG. 5 TOP FACTORS IMPACTING ON GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014-2020)FIG. 6 TOP INVESTMENT POCKETS OF ANTI-INFLAMMATORY THERAPEUTICS MARKET (2014)FIG. 7 TOP WINNING STRATEGIES IN ANTI-INFLAMMATORY THERAPEUTICSMARKETFIG. 8 PHARMACEUTICALS REGULATORY PATHWAY (U.S.)FIG. 9 PORTERand#39;S FIVE FORCES ANALYSISFIG. 10 VALUE CHAIN OF GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKETFIG. 11 MARKET SHARE ANALYSIS, 2014FIG. 12 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)FIG. 13 FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 14 FINANCIAL REVENUES BY YEAR ($MILLION)FIG. 15 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 16 ABBVIE, INC. FINANCIAL REVENUES BY YEAR ($MILLION)FIG. 17 FINANCIAL REVENUES OF HUMIRA ($MILLION)FIG. 18 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 19 PHARMACEUTICALS SALES BY GEOGRAPHY (2014)FIG. 20 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 21 GLAXOSMITHKLINEand#39;S FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 22 FINANCIAL REVENUES BY THERAPY AREAFIG. 23 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 24 FINANCIAL REVENUES BY YEAR ($MILLION)FIG. 25 FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 26 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 27 FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 28 FINANCIAL REVENUES BY SEGMENT (2014)FIG. 29 SWOT ANALYSIS andamp; STRATEGIC CONCLUSIONSFIG. 30 FIANANCIAL REVENUES BY THERAPEUTIC SEGMENTS (2014)FIG. 31 FINANCIAL REVENUES OF PHARMACEUTICALS BY REGIONFIG. 32 SWOT ANALYSIS AND STRATEGIC CONCLUSIONSFIG. 33 FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)FIG. 34 SWOT ANALYSIS AND STRATEGIC CONCLUSIONSFIG. 35 FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 36 FINANCIAL REVENUES BY YEAR ($MILLION)FIG. 37 SWOT ANALYSIS AND STRATEGIC CONCLUSIONSFIG. 38 FINANCIAL REVENUES BY PRODUCT (2014)FIG. 39 FINANCIAL REVENUES BY YEAR ($MILLION)FIG. 40 SWOT ANALYSIS AND STRATEGIC CONCLUSIONSLIST OF TABLESTABLE 1 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET MODERATE GROWTH SCENARIO, REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)TABLE 2 GLOBAL ANTI-INFLAMMTORY THERAPEUTICS MARKET RAPID GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)TABLE 3 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET DIMINISHING GROWTH SCENARIO REVENUE BY GEOGRAPHY, 2020-2025 ($ MILLION)TABLE 4 PATENT EXPIRY OF MAJOR BRANDSTABLE 5 PROJECTED INCIDENCE OF ARTHRITIS IN U.STABLE 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET, BY INDICATION, 2014-2020, ($MILLION)TABLE 7 GLOBAL ARTHRITIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 8 GLOBAL RESPIRATORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 9 GLOBAL MULTIPLE SCLEROSIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 10 GLOBAL PSORIASIS ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 11 GLOBAL INFLAMMTORY BOWEL DISEASE ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 12 GLOBAL OTHER INFLAMMTORY DISEASES ANTI INFLAMMTORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, $MILLIONTABLE 13 GLOBAL ANTI INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020, $MILLIONTABLE 14 GLOBAL TOP SELLING BIOLOGIC ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)TABLE 15 GLOBAL ANTI-INFLAMMATORY BIOLOGICS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 16 GLOBAL NSAIDS THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 17 GLOBAL TOP SELLING CORTICOSTEROIDS ANTI-INFLAMMATORY BRANDS, 2014 ($MILLION)TABLE 18 GLOBAL CORTICOSTEROIDS ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)TABLE 19 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)TABLE 20 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)TABLE 21 NORTH AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)TABLE 22 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)TABLE 23 EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)TABLE 24 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)TABLE 25 ASIA PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)TABLE 26 LAMEA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS, 2014-2020 ($MILLION)TABLE 27 LATIN AMERICA ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY, 2014-2020 ($MILLION)TABLE 28 PFIZER INC SNAPSHOTTABLE 29 ABBVIE INC. SNAPSHOTTABLE 30 JOHNSON andamp; JOHNSON SNAPSHOTTABLE 31 GLAXOSMITHKLINE SNAPSHOTTABLE 32 MERCK andamp; CO SNAPSHOTTABLE 33 NOVARTIS AG SNAPSHOTTABLE 34 F. HOFFMANN-LA ROCHE AG SNAPSHOTTABLE 35 ELI LILLY SNAPSHOTTABLE 36 ASTRAZENECA SNAPSHOTTABLE 37 AMGEN INC SNAPSHOT

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Naproxen Sodium For Injection Industry, 2016 Market Research Report

Global and Chinese Naproxen Sodium For Injection Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Naproxen Sodium For Injection Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Naproxen Sodium For Injection ...

Global and Chinese Dimethyl Quinoline Industry, 2016 Market Research Report

Global and Chinese Dimethyl Quinoline Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Dimethyl Quinoline Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Dimethyl Quinoline industry with a focus ...

Global and Chinese Methyl Isobutyl Quinoline Industry, 2016 Market Research Report

Global and Chinese Methyl Isobutyl Quinoline Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Methyl Isobutyl Quinoline Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Methyl Isobutyl Quinoline industry ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market

  • October 2016
    277 pages
  • Therapy  

    Infectious Dise...  

View report >

Therapy Market in Australia - Forecast

  • October 2016
    8 pages
  • Vaccine  

    Infectious Dise...  

    Neurology  

  • Australia  

View report >

Analgesic Market in Australia

  • October 2016
    6 pages
  • Analgesic  

    Palliative Medi...  

    Pain Relief  

  • Australia  

View report >

Therapy Market

3 months ago

Related Market Segments :

Anti Rheumatic
Therapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.